Cancer · July 2, 2026
Prediction Market Gives 83 Percent Odds to Sellas Leukemia Drug Trial Success
Market predictions show strong confidence in an upcoming AML drug trial success with 83% odds of positive results....
Cancer · July 1, 2026
FDA Approves First Cell Therapy to Prevent Graft Versus Host Disease
FDA approves first-of-its-kind Treg cell therapy offering new hope for blood cancer transplant patients....
Breakthrough · June 28, 2026
Common Bleeding Drug Linked to Lower Liver Failure Risk After Surgery
Michigan State researchers challenge conventional understanding of liver regeneration after surgery with potential therapeutic imp...
Cancer · June 24, 2026
FDA Approves First Engineered T-Cell Therapy for Teens With Rare Sarcoma
FDA grants full approval for engineered cell therapy with expanded indication, helping more patients with blood cancers....
Prevention · June 11, 2026
New Initiative Aims to Boost Blood Cancer Trial Diversity to 20 Percent
IMPACT grant initiative tackles racial disparities in blood cancer research and discovery....
Treatment · June 2, 2026
New Nilotinib Formulation Offers Flexible Dosing for CML Patients
FDA approval of a new orally disintegrating tablet formulation offers patients greater treatment flexibility for chronic myeloid l...
Cancer · May 14, 2026
FDA Approves First BCL2 Inhibitor for Tough-to-Treat Mantle Cell Lymphoma
BeOne receives FDA approval for a new mantle cell lymphoma therapy, establishing an entirely new class of treatment options for pa...
Cancer · May 14, 2026
FDA Approves Two New Drug Regimens for Hard to Treat Blood Cancers
FDA approvals of Beqalzi and Inqovi represent important new treatment options for patients with mantle cell lymphoma and blood can...
Research · April 15, 2026
Community Engagement Proves Critical for Success in Landmark Sickle Cell Trial
Building community trust in clinical trials leads to greater participation and more successful research outcomes....
Breakthrough · March 18, 2026
Michigan Patient First in State to Receive Groundbreaking Sickle Cell Gene Therapy
First Michigan patient receives groundbreaking sickle cell gene therapy, potentially offering a cure....